6-Bromo-3-nitro-1H-pyrrolo[3,2-b]pyridine(CAS: 1190311-94-4)

6-Bromo-3-nitro-1H-pyrrolo[3,2-b]pyridine falls under various regulatory guidelines including GHS classification for hazards, REACH regulations for the European market, and FDA and EPA requirements for pharmaceutical and environmental safety. It is important to comply with specific storage, handling, and disposal regulations to ensure safety and legal compliance.

Alternatives to 6-Bromo-3-nitro-1H-pyrrolo[3,2-b]pyridine include other heterocyclic compounds with similar structural features such as 6-chloro-3-nitro-1H-pyrrolo[3,2-b]pyridine or 6-bromo-3-nitro-1H-pyrrolo[2,3-b]pyridine. These alternatives can be used as substitutes depending on the specific requirements of the synthesis.

The research trend for 6-Bromo-3-nitro-1H-pyrrolo[3,2-b]pyridine is focused on its potential applications in medicinal chemistry, particularly in drug discovery and development. Market trends indicate increasing interest due to its antimicrobial and anti-inflammatory properties, leading to new research fields and applications.

Waste containing 6-Bromo-3-nitro-1H-pyrrolo[3,2-b]pyridine should be collected and disposed of in accordance with local and international regulations. This typically involves neutralization or incineration to minimize environmental impact. Professional waste disposal services are recommended to ensure compliance with safety and environmental standards.